San Francisco is one step closer to decriminalizing psychedelics

by Team Inc.

2022-09-13-San Francisco gets one step closer to decriminalizing psychedelics

On Tuesday, the San Francisco Board of Trustees unanimously passed a motion to decriminalize plant-based psychedelics such as psilocybin and ayahuasca.

The measure, resolution #220896, concerns entheogenic plants, another term for psychoactive plants, or plants that can cause changes in perception and mood. It calls on the San Francisco Police Department to give "the lowest priority" to investigations and arrests related to the use of such substances.

Psychedelics more accepted

This category of drugs includes psilocybin, magic mushrooms and peyote, which are controlled by the US Drug Enforcement Administration as "Schedule 1" substances. (Ayahuasca doesn't technically fall into this category, but its active ingredient, DMT, does.)

These substances are not accepted by the DEA for medicinal use and are at the top of the list for enforcement. So far, it's not clear what impact the motion will actually have on psychedelics oversight in San Francisco. Some psychedelic practices, such as the use of ayahuasca in certain religious contexts, are already protected in the US under the principle of religious freedom, according to the resolution.

Health benefits of psychedelics

The measure urges the California and federal governments to decriminalize its use. San Francisco is following in the footsteps of Oakland, which decriminalized plant-based psychedelics in 2019.
The resolution defines entheogens as the full spectrum of plants, fungi and natural materials that can inspire personal and spiritual well-being, benefit psychological and physical well-being, and restore man's direct relationship with nature.

The resolution cites research showing that psychedelics have meaningful health benefits, as they have been used in the treatment of PTSD, opiate and methamphetamine addiction, depression, and cluster headaches.

Source: edition.cnn.com (EN)

Related Articles

Leave a comment

[adrate banner="89"]